Search For "biotech"
Covaxin production takes 120 days depending on technology framework, regul
Updated : 4 years, 9 months ago IST
New Delhi [India], May 28 (ANI): Amid reports of shortage of its COVID-19 vaccine in the country, Bharat Biotech on Friday said that the timeline for manufacturing, testing, and release for a batch of Covaxin is approximately 120 days, depending on the technology framework and regulatory
Read More
IIL partners with Bharat Biotech to produce drug substance for Covaxin fro
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], May 28 (ANI): Indian Immunologicals Limited (IIL) has partnered with Hyderabad-based Bharat Biotech to manufacture drug substance for 'Covaxin' to ramp up the production of the COVID-19 vaccine.
Read More
Rajasthan govt will appeal to SC to direct Centre to float global tenders
Updated : 4 years, 9 months ago IST
Jaipur (Rajasthan) [India], May 27 (ANI): Rajasthan Health Minister Dr Raghu Sharma on Thursday said that the state government will appeal to the Supreme Court to direct the Government of India to issue global tenders and procure COVID-19 vaccines.
Read More
WHO seeks more data on China's CoronaVac COVID-19 vaccine
Updated : 4 years, 9 months ago IST
Geneva [Switzerland], May 27 (ANI): The World Health Organization (WHO) is seeking more data on China's Sinovac Biotech-made COVID-19 vaccine, named CoronaVac, as it weighs whether to authorise a second Chinese vaccine under international pressure to help distribute more shots.
Read More
Bharat Biotech says EUL for COVAXIN submitted to WHO, approval expected by
Updated : 4 years, 9 months ago IST
New Delhi [India], May 26 (ANI): COVID-19 vaccine COVAXIN's manufacturer Bharat Biotech on Tuesday said application for Emergency Use Listing (EUL) of its vaccine has been submitted to World Health Organisation (WHO), Geneva, and regulatory approvals are expected between July and Septembe
Read More
Bharat Biotech submits 90 pc documentation, confident of WHO emergency use
Updated : 4 years, 9 months ago IST
New Delhi [India], May 24 (ANI): Bharat Biotech is confident about obtaining the World Health Organization's (WHO) Emergency Use Listing for its COVID-19 vaccine given its experience of getting its other vaccines pre-qualified and has submitted 90 per cent of the documentation required for E
Read More
Paediatric trials of Covaxin may begin in June
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], May 24 (ANI): Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company's Business Development and International Advocacy Head Dr Raches Ella on Sunday.
Read More
Bharat Biotech to scale up Covaxin production, eyes 200 mn doses annually
Updated : 4 years, 10 months ago IST
New Delhi [India], May 20 (ANI): Amid the growing demand for vaccines in the country, Hyderabad-based Bharat Biotech has announced ramping up of additional manufacturing capacities for Covaxin at Chiron Behring Vaccines in Gujarat's Ankleshwar.
Read More
Quash notification allowing phase 2/3 trials of Covaxin in 2-18 years age
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI): A Public Interest Litigation (PIL) has been moved in Delhi High Court seeking quashing of Centre's "notification" of May 13, which has accorded permission for conduct of phase two/three clinical trials of Covaxin in the age group 2 to 18 years to its manuf
Read More
Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
Read More
Baz Brandings, Trades LLP partner with Polyamyna Nanotech Inc for antimicr
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI/ThePRTree): Intending to increase the level of hygiene and cleanliness, Baz Brandings and Trades LLP has partnered with Polyamyna Nanotech Incorporation (PNI), a Canadian-based Scientific Biotech company that ventures to develop next-generation antimicrobial te
Read More
Bengaluru residents face difficulties in securing COVAXIN doses
Updated : 4 years, 10 months ago IST
Bengaluru (Karnataka) [India], May 16 (ANI): Amid the rising COVID-19 cases in Karnataka, locals in Bengaluru say that they have been facing a lot of difficulties in getting the COVAXIN vaccine.
Read More